Inventor
OLSON STEVEN H
US27 patents
⚠️ This page may combine multiple inventors who share the name “OLSON STEVEN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
18 patentsUS10221162B2Mar 5, 2019
Triazole agonists of the APJ receptor
AMGEN INC12 citations92
US9868721B2Jan 16, 2018
Triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9845310B2Dec 19, 2017
Intermediates for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9751864B2Sep 5, 2017
Methods for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9745286B2Aug 29, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9656998B2May 23, 2017
Intermediates for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9656997B2May 23, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9573936B2Feb 21, 2017
Triazole agonists of the APJ receptor
AMGEN INC19 citations92
US10150760B2Dec 11, 2018
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor
AMGEN INC8 citations84
US9988369B2Jun 5, 2018
Heterocyclic triazole compounds as agonists of the APJ receptor
AMGEN INC8 citations83
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US9376425B2Jun 28, 2016
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC12 citations82
US11046680B1Jun 29, 2021
Heteroaryl-substituted triazoles as APJ receptor agonists
AMGEN INC2 citations62
US10736883B2Aug 11, 2020
Triazole furan compounds as agonists of the APJ receptor
AMGEN INC1 citations62
US9758495B2Sep 12, 2017
Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC1 citations51
US11407721B2Aug 9, 2022
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC0 citations50
US9365522B2Jun 14, 2016
Pyrazole amide derivative
AMGEN INC2 citations47
MERCK & CO INC
5 patentsUS6730690B2May 4, 2004
11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
MERCK & CO INC108 citations97
US6916846B2Jul 12, 2005
Coumermycin analogs as chemical dimerizers of chimeric proteins
MERCK & CO INC21 citations87
US7179802B2Feb 20, 2007
11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
MERCK & CO INC14 citations84
US6630510B1Oct 7, 2003
Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
MERCK & CO INC6 citations58
US7329683B2Feb 12, 2008
11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
MERCK & CO INC0 citations37